Novavax’s Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
(Adnkronos) – GAITHERSBURG, Md., Nov. 28, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted
